Navigation Links
Registration Opens Today for ASGCT's 23rd Annual Meeting in Boston

Registration is now open for the American Society of Gene & Cell Therapy’s (ASGCT) 23rd Annual Meeting, which will be held at the Hynes Convention Center May 12-15, 2020, in Boston. The meeting is the premier event in the field of gene and cell therapy and brings together scientists, physicians, patient advocates, and other stakeholders with the goal of advancing gene and cell therapies to alleviate human disease.

The 23rd Annual Meeting is expected to be the Society’s largest ever, and attendees are encouraged to register early and to reserve their hotel rooms as soon as possible as the latter will sell out well before the meeting. An early registration discount is available through April 10, and groups of five or more are eligible for an additional discount. Pre-Meeting Workshops and the Closing Night Reception can be added to annual meeting registration.

Abstract submission for the 23rd Annual Meeting is now open and runs through January 29.
International attendees can generate invitation letters online to apply for a VISA immediately after registering or submitting an abstract. More information about registration is available on the annual meeting website.

Hotel blocks for the Sheraton Boston Hotel and Boston Marriott Copley Place are also available now. ASGCT room blocks historically sell out months before the annual meeting, and once the ASGCT block is completely full, there's no guarantee attendees will be able to get the same room rate during the meeting.

More details about annual meeting programming will be posted on the website as they are confirmed. For any questions about the annual meeting, please contact [ __title__ ].

The American Society of Gene & Cell Therapy is the primary professional membership organization for scientists, physicians, patient advocates, and other professionals with interest in gene and cell therapy. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, biotechnology and pharmaceutical companies. ASGCT advances knowledge, awareness, and education leading to the discovery and clinical application of gene and cell therapies to alleviate human disease to benefit patients and society.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology technology :

1. NanoScientific Symposium on SPM at SUNY Polytechnic Announces Registration for Live Stream of Event Sept. 19, 2018
2. Biohaven Files Registration Statement for Proposed Public Offering of its Common Shares
3. CannaTech, Israels 3rd Annual Summit for Accelerating Cannabis Innovation Announces Registration
4. Morf Playbook™ Training on Smartphones Presents New Course on Medical Device Establishment Registration and Listing
5. MEI Pharma Announces Positive Results from Phase II Study of Pracinostat in Acute Myeloid Leukemia, Plans to Initiate Phase III Registration Study
6. 2016 iLab/CORES User Group Conference Open for Registration
7. Conferee Registration Opens for Pittcon 2016
8. ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma
9. ProNAi Therapeutics Files Registration Statement for Proposed Initial Public Offering
10. Nivalis Therapeutics Files Registration Statement for Initial Public Offering of Common Stock
11. Integrates Engagement Management Technology, Captive Reach, Providing a Robust User Experience for Mobile-first Registration Platform
Post Your Comments:
(Date:2/19/2020)... ... February 18, 2020 , ... ... populations down to the strain level, recently unveiled a novel DNA isolation product. ... and unbiased isolation of high molecular weight (HMW) single-stranded DNA (ssDNA) in excess ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... the life sciences industry, today announced the opening of a new office in ... Red Nucleus R&D. , Red Nucleus announced the new office in response to ...
(Date:2/11/2020)... , ... February 11, 2020 ... ... is pleased to announce the successful results from a long-term follow-up clinical ... the Inspan interspinous fixation device (INSPAN LLC). Unlike extension block design, the ...
(Date:2/10/2020)... ... ... R3 Medical Training announced it is now registering for its next Comprehensive ... is hands on involving real patients and stem cell biologics, with every attendee receiving ... Training Course has received rave reviews from attendees, who love the hands on nature ...
Breaking Biology Technology:
(Date:1/22/2020)... ... January 21, 2020 , ... Lifecycle Biotechnologies announces the new line of high purity ... needs based on their process requirements and accurately weighed to 0.001 of a gram. The ... Salts , Sugars , Carbohydrates , Phosphates , ...
(Date:1/10/2020)... ... January 09, 2020 , ... Cutting Edge Spine, ... the 510(K) clearance and commercial launch of the latest addition to its bioactive ... The EVOL®ha-DLIF is made of PEEK-OPTIMA HA Enhanced material supplied by Invibio Biomaterial ...
(Date:1/7/2020)... ... January 07, 2020 , ... Lifecycle Biotechnologies ... just part numbers like what can be found in most catalogs, but rather, ... that is all linked to the impact it has on the global life ...
Breaking Biology News(10 mins):